Disclaimer

Please note that the following pages are exclusively reserved for health care professionals in countries with applicable health authority product registrations. To the extent this site contains information, reference guides and databases intended for use by licensed medical professionals, such materials are not intended to offer professional medical advice. Prior to use, please consult device labeling for prescriptive information and operating instructions.

US: CAUTION – Investigational Device. Limited by Federal (or United States) law to investigational use.

New York Valves

Live Case

See Trilogy Live at NY Valves.

Don't miss a live Trilogy implant case broadcasting from Columbia University Medical Center during NY Valves. 
Tune in to see the therapy in action.
Wednesday, June 24, 2:50 – 3:50 PM EDT
Live Case Theater | Room 405
JENAVALVE SPONSORED SYMPOSIUM

Rethinking Aortic Regurgitation in 2026: Gaps, Guidelines, and Innovation

Join our JenaValve sponsored symposium to evaluate emerging data against current guidelines, review real-world TAVR for AR cases with the Trilogy System, and explore the evolving landscape of care for patients with AR.
Wednesday, June 24, 12:00 - 1:15 PM
iCOACH Theater | Room 502 | Level 5
LATE-BREAKING CLINICAL SCIENCE

Must-See Trilogy data on the main stage.

New Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement for Pure Aortic Regurgitation: Results from the ALIGN-AR Study.
James McCabe, MD
Friday, June 26th, 10:15 — 11:45 AM EDT
Heart Team Arena | Room 406 | Level 4

TAVR with the JenaValve Trilogy System in Patients with Continuous-Flow LVADs
Ravi Ramana, DO
Friday, June 26th, 1:45 -2:45 PM EDT
Heart Team Arena | Room 406 | Level 4

TAVR for Aortic Regurgitation: The Next Revolution?

Moderators: Hendrik Treede, Torsten P. Vahl
Discussants: Vratika Agarwal, Stephan Baldus, Sabine Bleiziffer, Harsh Golwala, Eberhard Grube, Lauren Sharan Ranard
Thursday, June 25th, 3:55 — 4:55 PM EDT
Heart Team Arena | Room 406 | Level 4
Don't miss this session as structural heart experts explore the future of transcatheter treatment for aortic regurgitation — featuring real-world case presentations, multimodality imaging strategies, and a look at the latest surgical and transcatheter approaches shaping the next frontier in AR care.
Close Download
The information in this Reimbursement Guide is provided for educational purposes only and is not intended to be coding or billing advice. This coding information is based upon publicly available information and is current as of April 1, 2026 and subject to change without notice. JenaValve Technology, Inc. cannot guarantee that any product or service billed with the codes listed will be covered or, if covered, the listed payment amount will be paid by any payer. It is the responsibility of the provider to select appropriate codes for each patient and to submit appropriate codes, charges, and modifiers for services rendered. Providers should contact insurers to verify correct coding procedures prior to submitting claims related to the use of JenaValve products. In all cases, providers must bill according to the rules, policies and procedures of individual payers. The medical record should document that the product or procedure was medically necessary and furnished or performed as reported. Clinical need, not reimbursement amount, should always drive clinical decision making. If you have any questions about appropriate billing for products or services, please consult your local payer. The information contained in this guide is provided to assist providers in understanding the reimbursement process. It is intended to assist providers in obtaining accurate and appropriate reimbursement for the healthcare services provided. It is not intended to increase or maximize reimbursement by any payer. It is strongly recommended that providers consult with their payer organizations with regard to local reimbursement policies. The information contained herein is provided for information purposes only and represents no statement, promise, or guarantee by JenaValve Technology, Inc. concerning levels of reimbursement, payment, or charge. Similarly, all CPT codes are supplied for information purposes only and represent no statement, promise, or guarantee by JenaValve Technology, Inc. that these codes will be appropriate or that reimbursement will be made. For additional information, please contact us at reimbursement.usa@jenavalve.com.